Efficient Targeting and Activation of Antigen-Presenting Cells In Vivo after Modified mRNA Vaccine Administration in Rhesus Macaques

This publication has 50 references indexed in Scilit:

• Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction
  Nature Biotechnology, 2013
• Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis
  New England Journal of Medicine, 2013
• Type I IFN Counteracts the Induction of Antigen-Specific Immune Responses by Lipid-Based Delivery of mRNA Vaccines
  Molecular Therapy, 2013
• Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase L
  Nucleic Acids Research, 2011
• Human and rhesus plasmacytoid dendritic cell and B-cell responses to Toll-like receptor stimulation
  Immunology, 2011
• Adjuvants and Vector Systems for Allergy Vaccines
  Immunology and Allergy Clinics of North America, 2011
• Vaccine Adjuvants: Putting Innate Immunity to Work
  Immunity, 2010
• The microbial mimic poly IC induces durable and protective CD4⁺T cell immunity together with a dendritic cell targeted vaccine
  Proceedings of the National Academy of Sciences, 2008
• Myeloid and Plasmacytoid Dendritic Cells Are Susceptible to Recombinant Adenovirus Vectors and Stimulate Polyfunctional Memory T Cell Responses
  The Journal of Immunology, 2007
• Type I interferons produced by dendritic cells promote their phenotypic and functional activation
  Blood, 2002